Therefore, studying NfL as a biomarker for neurological diseases has gained attention, and this protein has been reported to be increased in blood and CSF in a variety of neurological disorders, such as AD, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), or multiple sclerosis (MS) [24]. This evidence concerns the gene NEFL and frontotemporal dementia.